We are live on ! Find out more
PLSE icon

Pulse Biosciences
PLSE

29 hedge funds and large institutions have $8.89M invested in Pulse Biosciences in 2017 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

547% more capital invested

Capital invested by funds: $1.37M → $8.89M (+$7.52M)

164% more funds holding

Funds holding: 11 → 29 (+18)

1.48% more ownership

Funds ownership: 1.6% → 3.08% (+1.5%)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

Holders
29
Holders Change
+18
Holders Change %
+163.64%
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
3
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.9M
2
CCM
Cadence Capital Management
Massachusetts
+$412K
3
BlackRock
BlackRock
New York
+$210K
4
TC
TFS Capital
Pennsylvania
+$191K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$189K

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$271K
2
JAM
JW Asset Management
Florida
-$211K
3
UBS Group
UBS Group
Switzerland
-$137K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$3.65M +$1.9M +139,572 +355%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$866K +$189K +13,910 +49%
CCM
3
Cadence Capital Management
Massachusetts
$617K +$412K +30,230 New
UBS Group
4
UBS Group
Switzerland
$526K -$137K -10,064 -28%
Goldman Sachs
5
Goldman Sachs
New York
$469K -$271K -19,898 -46%
JAM
6
JW Asset Management
Florida
$448K -$211K -15,500 -41%
BlackRock
7
BlackRock
New York
$314K +$210K +15,402 New
TC
8
TFS Capital
Pennsylvania
$286K +$191K +14,019 New
Millennium Management
9
Millennium Management
New York
$244K +$163K +11,975 New
Jane Street
10
Jane Street
New York
$243K +$162K +11,908 New
Northern Trust
11
Northern Trust
Illinois
$208K +$138K +10,169 New
VKH
12
Virtu KCG Holdings
New York
$205K +$137K +10,065 New
LCS
13
Levin Capital Strategies
New York
$204K +$136K +10,000 New
SCM
14
Segantii Capital Management
Hong Kong
$165K +$110K +8,100 New
Morgan Stanley
15
Morgan Stanley
New York
$138K +$91.7K +6,740 New
Barclays
16
Barclays
United Kingdom
$104K +$69.4K +5,100 New
Bank of Montreal
17
Bank of Montreal
Ontario, Canada
$41K +$27.2K +2,000 New
Bank of America
18
Bank of America
North Carolina
$27K +$1.02K +75 +6%
Deutsche Bank
19
Deutsche Bank
Germany
$22K +$14.7K +1,080 New
Fifth Third Bancorp
20
Fifth Third Bancorp
Ohio
$20K – – –
FMA
21
FNY Managed Accounts
New York
$20K +$13.6K +1,001 New
KKAMG
22
Kernodle & Katon Asset Management Group
Arkansas
$17K +$11.2K +820 New
IWM
23
IHT Wealth Management
Illinois
$16K +$12.6K +924 New
AIM
24
Acrospire Investment Management
Illinois
$14K +$9.54K +701 New
Creative Planning
25
Creative Planning
Kansas
$10K +$6.47K +475 New
1
2

PLSE Hedge Fund Activity: Q1 2017 in Review

29 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q1 2017, worth a combined $8.89M — up 547% from $1.37M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new PLSE positions and 0 closed out — a net gain of 21 holders — while 3 added to existing stakes and 3 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.9M. The largest seller was Goldman Sachs, cutting an estimated $271K.

  • 29 institutional investors held Pulse Biosciences (PLSE) as of Q1 2017, up from 11 in Q4 2016.
  • Funds reported $8.89M of Pulse Biosciences stock for Q1 2017, up 547% quarter-over-quarter.
  • 21 funds opened new Pulse Biosciences positions in Q1 2017 and 0 closed out, a net change of +21 holders.
  • The largest Pulse Biosciences buyer in Q1 2017 was Vanguard Group, an estimated $1.9M added.
  • The largest Pulse Biosciences seller in Q1 2017 was Goldman Sachs, an estimated $271K sold.

Based on aggregated 13F filings for Q1 2017.